Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

  • There is currently no data for N4P

Trading Update

31 Jan 2012 07:00

RNS Number : 4379W
Ultima Networks PLC
31 January 2012
 



 

Ultima Networks plc

("Ultima" or the "Group")

Trading Update

31st January 2012

Ultima, the IT and Green Technology Company, is pleased to provide an update on trading following the end of its financial year on 31 December 2011.

 

The Board of Ultima are pleased to announce that it has seen growth in all of its operating divisions during the year ended 31 December 2011 and that it expects to report turnover and net profit ahead of market expectations. The Group operates through three divisions: IT Services, Green technology products and Green power. These divisions are involved respectively in the sale of software to the legal profession, the development and sale of specialist electrical goods and the development of clean power generation through solar installations in Spain, Italy and the United Kingdom.

 

The IT Services division provides computer application software and related support and other services to small and medium size legal practices in England and Wales. The division operates under the name Cognito Software Limited and during the year launched its latest integrated legal software suite which is marketed under the name "FiLos". The introduction of FILOS marketed alongside the existing software range is expected to attract interest from larger legal practices and spearhead the continued growth in the division's profitability.

The Green technology products division has seen continued growth in its range of electrically powered bicycles marketed under the brand names "Powacycle" and "Infineum". Significant sales growth in continental Europe more than compensated for the difficult market conditions for luxury goods in the UK. The division accounted for 58% of sales in 2011, is expected to increase in 2012 led by the introduction of new models, continued R&D activity and targeted marketing.

The Green power division completed over 500 KW of solar photovoltaic installations throughout the UK during 2011. It has retained ownership of 400 KW for future sale; in the meantime the generating capacity retained by the division will contribute to an increase in recurring revenue received under the "FITS" (Feed in tariff) programme estimated at £120,000 per annum. The installations met the 12th December 2011 deadline (set by the government in order to receive the higher tariff for the 25 year life of the scheme). The division is currently expanding its operations to include the Renewable Heat Installations using Ground Source Heat pumps, where the Feed in Tariff is currently available to commercial organisations and expected to be extended to domestic consumers by October 2012. The investment made into a 100KW solar park in Spain is operating and expected to increase its contribution to the division's revenue during 2012.

The continued investments in new technology with a strong R&D effort reinforces the company's focus on achieving growth and profitability through the introduction of new products and continuous attention to the company's competitive position.

Ultima also announces that on 19 September 2011 it transferred its trading platform from SEAQ to SETSqx (Stock Exchange Electronic Trading Service- quotes and crosses). SETSqx combines the existing non-electronic market maker quote with periodic electronic auctions designed to concentrate liquidity. The auctions allow both market makers and non-market makers to enter electronic limit orders and to participate in the auctions.

The Board of Ultima expects to release its results for the year ended 31st December 2011 during May 2012.

Enquires:

Ultima Networks plc 01279 821200

Prof. Humayun Mughal, Chairman and CEO

 

Allenby Capital Limited (nominated adviser and broker) 0203 328 5656

Nick Athanas

Dan Robinson

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSDFEDSFESEDF
Date   Source Headline
17th Mar 202612:14 pmRNSResult of General Meeting and Change of Name
27th Feb 20267:00 amRNSNotice of GM and Proposed Change of Name
24th Feb 20267:00 amRNSCEO Appointment & Name Change Thalia Therapeutics
17th Dec 20257:00 amRNSBusiness and Operational Update
25th Sep 20257:00 amRNSInterim Results
23rd Sep 20257:00 amRNSPartnership with University of Strathclyde’s CMAC
22nd Sep 20257:00 amRNSN4 Pharma’s Nuvec® Targets Lung Cancer Cells
19th Sep 20257:00 amRNSNotice of Results, Analyst & Investor Presentation
11th Sep 20257:00 amRNS-RInvestor Event and Presentation
30th Jul 20251:55 pmRNS-RArticle on Nuvec®’s Potential in RNA Therapeutics
14th Jul 20257:00 amRNS-RInvestor Webinar
8th Jul 20257:00 amRNSDirectorate Change
30th Jun 20252:15 pmRNSResult of AGM
30th Jun 20257:00 amRNSAGM Statement
25th Jun 20257:00 amRNS-RInsight Event for Retail Investors
6th Jun 20257:00 amRNSFinal Results, Annual Report and Notice of AGM
27th May 20257:00 amRNS-REstablishment of New Senior Leadership Team
23rd May 202512:37 pmRNSTR-1: Notification of major holdings
21st May 20254:11 pmRNSHolding(s) in Company
15th May 20253:13 pmRNSChange of Registered Address
12th May 20257:00 amRNSN4 101 In Vivo Study Results
9th May 20258:24 amRNSHolding(s) in Company
29th Apr 20254:25 pmRNSHolding(s) in Company
29th Apr 202511:05 amRNSHolding(s) in Company
28th Apr 20252:30 pmRNSHolding(s) in Company
23rd Apr 20252:32 pmRNSTR-1: Standard form notification of major holdings
22nd Apr 202511:56 amRNSResult of General Meeting
4th Apr 20257:08 amRNSPosting of Circular and Notice of General Meeting
1st Apr 20254:08 pmRNSPlacing and Subscription to raise £1,750,000
18th Feb 202512:34 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNS-RInvestor Webinar
27th Jan 20257:00 amRNS-RInvestor Webinar
16th Jan 20257:00 amRNS-RN4 Pharma Non-Executive Director Q&A
8th Jan 20257:00 amRNSDirectorate Changes
12th Dec 20247:00 amRNSN4 101 In Vitro Results
4th Dec 20247:00 amRNSNew Patent Filing
28th Nov 20247:00 amRNSGrant of Options
24th Sep 20247:00 amRNSInterim Results
17th Sep 20248:04 amRNSSRI Research Update
9th Sep 20247:00 amRNSDirector Appointment
23rd Aug 20248:30 amRNSChange of Auditor
20th Aug 20247:00 amRNSSRI Research Update
3rd Jul 20247:00 amRNSNanogenics Update
28th Jun 20247:00 amRNSTotal Voting Rights
19th Jun 20247:00 amRNSHolding(s) in Company
18th Jun 202412:34 pmRNSHolding(s) in Company
13th Jun 20244:52 pmRNSHolding(s) in Company
11th Jun 202411:16 amRNSNew Corporate Presentation
7th Jun 202410:18 amRNSPlacing and Subscription to raise £630,000
23rd May 20244:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.